AVNT
Price
$43.45
Change
+$0.61 (+1.42%)
Updated
Nov 2 closing price
Capitalization
3.99B
One day until earnings call
Intraday BUY SELL Signals
CBT
Price
$75.72
Change
+$1.29 (+1.73%)
Updated
Nov 2 closing price
Capitalization
3.91B
97 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

AVNT vs CBT

AVNT vs CBT Comparison Chart in %
View a ticker or compare two or three
VS
AVNT vs. CBT commentary
Nov 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AVNT is a Hold and CBT is a Hold.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for AVNT with price predictions
Nov 02, 2026

Momentum Indicator for AVNT turns positive, indicating new upward trend

AVNT saw its Momentum Indicator move above the 0 level on October 23, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 76 similar instances where the indicator turned positive. In 56 of the 76 cases, the stock moved higher in the following days. The odds of a move higher are at 74%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for AVNT just turned positive on October 21, 2026. Looking at past instances where AVNT's MACD turned positive, the stock continued to rise in 25 of 42 cases over the following month. The odds of a continued upward trend are 60%.

AVNT moved above its 50-day moving average on October 27, 2026 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for AVNT crossed bullishly above the 50-day moving average on November 02, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 10 of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 67%.

Following a +3.41% 3-day Advance, the price is estimated to grow further. Considering data from situations where AVNT advanced for three days, in 186 of 278 cases, the price rose further within the following month. The odds of a continued upward trend are 67%.

Bearish Trend Analysis

The RSI Indicator demonstrated that the stock has entered the overbought zone. This may point to a price pull-back soon.

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 8 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where AVNT declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 73%.

AVNT broke above its upper Bollinger Band on October 27, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for AVNT entered a downward trend on October 14, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is 40 (best 1 - 100 worst), indicating steady price growth. AVNT’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron PE Growth Rating for this company is 53 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of 67 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.635) is normal, around the industry mean (2.436). P/E Ratio (23.360) is within average values for comparable stocks, (-18.867). Projected Growth (PEG Ratio) (1.224) is also within normal values, averaging (1.548). Dividend Yield (0.025) settles around the average of (0.039) among similar stocks. P/S Ratio (1.130) is also within normal values, averaging (48.960).

The Tickeron SMR rating for this company is 78 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 96 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. AVNT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 82, placing this stock worse than average.

A.I.Advisor
a Summary for CBT with price predictions
Nov 02, 2026

CBT's Indicator enters downward trend

The Aroon Indicator for CBT entered a downward trend on November 02, 2026. Tickeron's A.I.dvisor identified a pattern where the AroonDown red line was above 70 while the AroonUp green line was below 30 for three straight days. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options. A.I.dvisor looked at 189 similar instances where the Aroon Indicator formed such a pattern. In 132 of the 189 cases the stock moved lower. This puts the odds of a downward move at 70%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The 50-day moving average for CBT moved below the 200-day moving average on October 26, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CBT declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 68%.

CBT broke above its upper Bollinger Band on November 02, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where CBT's RSI Oscillator exited the oversold zone, 18 of 22 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 82%.

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 40 of 60 cases where CBT's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 67%.

The Momentum Indicator moved above the 0 level on October 30, 2026. You may want to consider a long position or call options on CBT as a result. In 57 of 95 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 60%.

The Moving Average Convergence Divergence (MACD) for CBT just turned positive on October 22, 2026. Looking at past instances where CBT's MACD turned positive, the stock continued to rise in 33 of 50 cases over the following month. The odds of a continued upward trend are 66%.

Following a +2.53% 3-day Advance, the price is estimated to grow further. Considering data from situations where CBT advanced for three days, in 205 of 308 cases, the price rose further within the following month. The odds of a continued upward trend are 67%.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 4 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 59 (best 1 - 100 worst), indicating fairly steady price growth. CBT’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of 61 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.436) is normal, around the industry mean (2.436). P/E Ratio (21.092) is within average values for comparable stocks, (-18.867). Projected Growth (PEG Ratio) (0.320) is also within normal values, averaging (1.548). Dividend Yield (0.025) settles around the average of (0.039) among similar stocks. P/S Ratio (1.138) is also within normal values, averaging (48.960).

The Tickeron SMR rating for this company is 65 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 65 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 82, placing this stock slightly better than average.

FUNDAMENTALS RATINGS
AVNT vs CBT: Fundamental Ratings
AVNT
CBT
OUTLOOK RATING
1..100
2331
VALUATION
overvalued / fair valued / undervalued
1..100
67
Overvalued
61
Fair valued
PROFIT vs RISK RATING
1..100
9665
SMR RATING
1..100
7865
PRICE GROWTH RATING
1..100
4059
P/E GROWTH RATING
1..100
534
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CBT's Valuation (61) in the Industrial Specialties industry is in the same range as AVNT (67) in the null industry. This means that CBT’s stock grew similarly to AVNT’s over the last 12 months.

CBT's Profit vs Risk Rating (65) in the Industrial Specialties industry is in the same range as AVNT (96) in the null industry. This means that CBT’s stock grew similarly to AVNT’s over the last 12 months.

CBT's SMR Rating (65) in the Industrial Specialties industry is in the same range as AVNT (78) in the null industry. This means that CBT’s stock grew similarly to AVNT’s over the last 12 months.

AVNT's Price Growth Rating (40) in the null industry is in the same range as CBT (59) in the Industrial Specialties industry. This means that AVNT’s stock grew similarly to CBT’s over the last 12 months.

CBT's P/E Growth Rating (4) in the Industrial Specialties industry is somewhat better than the same rating for AVNT (53) in the null industry. This means that CBT’s stock grew somewhat faster than AVNT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AVNTCBT
RSI
ODDS (%)
Bearish Trend 1 day ago
65%
Bullish Trend 1 day ago
82%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
66%
Bullish Trend 1 day ago
67%
Momentum
ODDS (%)
Bullish Trend 1 day ago
74%
Bullish Trend 1 day ago
60%
MACD
ODDS (%)
Bullish Trend 1 day ago
60%
Bullish Trend 1 day ago
66%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
68%
Bullish Trend 1 day ago
67%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
63%
Bearish Trend 1 day ago
69%
Advances
ODDS (%)
Bullish Trend 7 days ago
67%
Bullish Trend 1 day ago
67%
Declines
ODDS (%)
Bearish Trend 25 days ago
73%
Bearish Trend 8 days ago
68%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
70%
Bearish Trend 1 day ago
68%
Aroon
ODDS (%)
Bearish Trend 1 day ago
62%
Bearish Trend 1 day ago
70%
COMPARISON
Comparison
Nov 03, 2026
Stock price -- (AVNT: $42.84 vs. CBT: $75.72)
Brand notoriety: AVNT and CBT are both not notable
Both companies represent the Chemicals: Specialty industry
Current volume relative to the 65-day Moving Average: AVNT: 149% vs. CBT: 155%
Market capitalization -- AVNT: $3.93B vs. CBT: $3.84B
AVNT [@Chemicals: Specialty] is valued at $3.93B. CBT’s [@Chemicals: Specialty] market capitalization is $3.84B. The market cap for tickers in the [@Chemicals: Specialty] industry ranges from $50 to $239.58B. The average market capitalization across the [@Chemicals: Specialty] industry is $11.72B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AVNT’s FA Score shows that 0 FA rating(s) are green while CBT’s FA Score has 1 green FA rating(s).

  • AVNT’s FA Score: 0 green, 5 red.
  • CBT’s FA Score: 1 green, 4 red.
According to our system of comparison, CBT is a better buy in the long-term than AVNT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AVNT’s TA Score shows that 5 TA indicator(s) are bullish while CBT’s TA Score has 5 bullish TA indicator(s).

  • AVNT’s TA Score: 5 bullish, 4 bearish.
  • CBT’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, both AVNT and CBT are a good buy in the short-term.

Price Growth

AVNT (@Chemicals: Specialty) experienced а +4.41% price change this week, while CBT (@Chemicals: Specialty) price change was +3.90% for the same time period.

The average weekly price growth across all stocks in the @Chemicals: Specialty industry was -0.01%. For the same industry, the average monthly price growth was -2.66%, and the average quarterly price growth was -8.05%.

Reported Earning Dates

AVNT is expected to report earnings on Nov 04, 2026.

CBT is expected to report earnings on Feb 08, 2027.

Industries' Descriptions

@Chemicals: Specialty (-0.01% weekly)

The specialty chemicals sector includes companies that produce chemicals and industrial gases, which are of relatively high-value, often made to customer specifications. Examples of specialty chemicals are electronic chemicals, industrial gases, coatings, adhesives and sealants, industrial and institutional cleaning chemicals. The products are often valued on the basis of their purposes/performances rather than for their composition. Linde Plc, Ecolab Inc., Air Products and Chemicals, Inc., and Dow, Inc. are some of the largest companies making specialty chemicals.

View a ticker or compare two or three
AVNT
Daily Signal:
Gain/Loss:
CBT
Daily Signal:
Gain/Loss:
Interact to see
Advertisement

AVNT and

Correlation & Price change

A.I.dvisor indicates that over the last year, AVNT has been closely correlated with OLN. These tickers have moved in lockstep 70% of the time. This A.I.-generated data suggests there is a high statistical probability that if AVNT jumps, then OLN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AVNT
1D Price
Change %
AVNT100%
+1.42%
OLN - AVNT
70%
Closely correlated
+3.12%
ASIX - AVNT
68%
Closely correlated
+1.11%
FUL - AVNT
63%
Loosely correlated
+3.74%
PPG - AVNT
63%
Loosely correlated
+4.49%
RPM - AVNT
62%
Loosely correlated
+5.23%
More

CBT and

Correlation & Price change

A.I.dvisor indicates that over the last year, CBT has been loosely correlated with ASIX. These tickers have moved in lockstep 62% of the time. This A.I.-generated data suggests there is some statistical probability that if CBT jumps, then ASIX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CBT
1D Price
Change %
CBT100%
+1.73%
ASIX - CBT
62%
Loosely correlated
+1.11%
OLN - CBT
61%
Loosely correlated
+3.12%
HUN - CBT
55%
Loosely correlated
+3.22%
DOW - CBT
55%
Loosely correlated
-1.50%
AVNT - CBT
53%
Loosely correlated
+1.42%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
IYG95.961.70
+1.80%
iShares US Financial Services ETF (IYG)
CNQQ18.320.16
+0.88%
Rayliant-ChinaAMC Transformative China Tech ETF (CNQQ)
MDIV16.18-0.02
-0.12%
Multi-Asset Diversified Income Index Fund (MDIV)
GROZ31.98-0.19
-0.58%
Zacks Focus Growth ETF (GROZ)
SOUX3.60-0.21
-5.47%
Defiance Daily Target 2X Long SOUN ETF (SOUX)